isovanillin has been researched along with harmine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnold, L; Cheng, N; Girod, DA; Hu, Q; Kakarala, K; Kumar, D; Miller, D; New, J; Nissen, E; Shnayder, Y; Snyder, V; Thomas, AR; Thomas, SM; Tsue, TT; Vishwakarma, V | 1 |
| Booth, L; Bordeaux, ZA; Dent, P; Kwatra, SG | 1 |
2 other study(ies) available for isovanillin and harmine
| Article | Year |
|---|---|
Potent Antitumor Effects of a Combination of Three Nutraceutical Compounds.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arum; Benzaldehydes; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cisplatin; Combined Modality Therapy; Curcuma; Curcumin; Dietary Supplements; ErbB Receptors; Harmine; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Molecular Docking Simulation; Peganum; Plant Extracts; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Xenograft Model Antitumor Assays | 2018 |
A novel combination of isovanillin, curcumin, and harmine (GZ17-6.02) enhances cell death and alters signaling in actinic keratoses cells when compared to individual components and two-component combinations.
Topics: Antineoplastic Agents; Cell Death; Curcumin; Harmine; Humans; Keratosis, Actinic | 2023 |